Apellis Pharmaceuticals, Inc. APLS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

48/100

1/7 Pass

SharesGrow Intrinsic Value

Apellis Pharmaceuticals, Inc. (APLS) has 20 ज्ञात अंदरूनी और संस्थागत धारक रिकॉर्ड पर. सबसे बड़े धारक हैं Morningside Venture Investments Ltd के साथ 12,806,342 शेयर. अन्य उल्लेखनीय धारकों में शामिल हैं Deschatelets Pascal और Francois Cedric.

पिछले 12 महीनों में, अंदरूनी लोगों ने किए हैं 86 लेनदेन APLS स्टॉक — 32 खरीद (मूल्य $19.26M) और 39 बिक्री (मूल्य $10.82M). अंदरूनी बिक्री ने खरीदारी को पार कर लिया है.

APLS इनसाइडर होल्डिंग

शीर्ष धारक

Morningside Venture Investments Ltd

12,806,342 शेयर

खरीद (12 माह)

$19.26M मूल्य

बिक्री (12 माह)

$10.82M मूल्य

12-माह लेनदेन गतिविधि

खरीदें 37%

बेचें 45%

शीर्ष इनसाइडर धारक

#	नाम	भूमिका	स्वामित्व वाले शेयर	अंतिम दाखिल तिथि	सापेक्ष आकार
1	Morningside Venture Investments Ltd	10 Percent Owner	12,806,342	2021-11-18	100%
2	Deschatelets Pascal	Chief Scientific Officer	1,177,222	2026-01-30	9%
3	Francois Cedric	Chief Executive Officer	372,815	2026-03-13	3%
4	Sullivan Timothy Eugene	Chief Financial Officer	152,041	2026-01-30	1%
5	Watson David O.	General Counsel	144,517	2026-01-30	1%
6	Boucher Kelley	Chief People Officer	127,804	2026-01-30	1%
7	Nicholson Nur	Chief Technical Officer	116,338	2026-01-30	1%
8	Delong Mark Jeffrey	Chief Business & Strat Officer	114,591	2026-02-13	1%
9	Meltzer Leslie	Chief Research and Development	107,024	2026-01-30	1%
10	Grossi Federico	Chief Medical Officer	94,884	2023-01-09	1%
11	Baumal Caroline	Chief Medical Officer	86,527	2026-01-23	1%
12	Townsend Adam J.	Chief Commercial Officer	84,050	2025-01-30	1%
13	Lewis Karen	Chief People Officer	70,251	2025-01-30	1%
14	Chopas James George	VP/chief Accounting Officer	65,955	2026-01-30	1%
15	Eisele Jeffrey	Chief Development Officer	55,312	2025-01-30	0%
16	Scheibler Lukas	Chief Research Officer	39,391	2023-12-05	0%
17	Brown Victoria L.	Program Team Lead	23,556	2023-01-24	0%
18	Wheeler Craig A	Director	14,684	2026-01-05	0%
19	Machiels Alec	Director	14,684	2026-01-05	0%
20	Chan Gerald	Director	14,684	2026-01-05	0%

हालिया लेनदेन (पिछले 12 माह)

तिथि	नाम	भूमिका	प्रकार	शेयर	मूल्य	मूल्य
2026-03-31	Biogen Inc.	Other: See Footnotes	अज्ञात	-	-	-
2026-03-11	Francois Cedric	Chief Executive Officer	उपहार (प्राप्त)	64,869	-	-
2026-03-02	Dolsten Mikael	Director	अज्ञात	-	-	-
2026-02-27	Dolsten Mikael	Director	RSU पुरस्कार	14,312	-	-
2026-02-11	Delong Mark Jeffrey	Chief Business & Strat Officer	सूचित बिक्री	368	$22.15	$8.15K
2026-02-03	Francois Cedric	Chief Executive Officer	विकल्प प्रयोग (बिक्री)	8,840	$3.76	$33.24K
2026-01-28	Meltzer Leslie	Chief Research and Development	RSU पुरस्कार	45,220	-	-
2026-01-28	Boucher Kelley	Chief People Officer	RSU पुरस्कार	30,146	-	-
2026-01-28	Delong Mark Jeffrey	Chief Business & Strat Officer	RSU पुरस्कार	36,606	-	-
2026-01-28	Chopas James George	VP/chief Accounting Officer	RSU पुरस्कार	16,150	-	-
2026-01-28	Nicholson Nur	Chief Technical Officer	RSU पुरस्कार	45,220	-	-
2026-01-28	Sullivan Timothy Eugene	Chief Financial Officer	RSU पुरस्कार	58,140	-	-
2026-01-28	Francois Cedric	Chief Executive Officer	RSU पुरस्कार	195,952	-	-
2026-01-28	Deschatelets Pascal	Chief Scientific Officer	RSU पुरस्कार	25,840	-	-
2026-01-28	Watson David O.	General Counsel	RSU पुरस्कार	55,986	-	-
2026-01-22	Baumal Caroline	Chief Medical Officer	सूचित बिक्री	2,797	$21.77	$60.88K
2026-01-22	Delong Mark Jeffrey	Chief Business & Strat Officer	सूचित बिक्री	3,371	$21.77	$73.37K
2026-01-22	Chopas James George	VP/chief Accounting Officer	सूचित बिक्री	2,064	$21.77	$44.92K
2026-01-22	Nicholson Nur	Chief Technical Officer	सूचित बिक्री	7,725	$21.77	$168.14K
2026-01-22	Sullivan Timothy Eugene	Chief Financial Officer	सूचित बिक्री	10,287	$21.77	$223.9K
2026-01-22	Francois Cedric	Chief Executive Officer	सूचित बिक्री	27,192	$21.77	$591.84K
2026-01-22	Deschatelets Pascal	Chief Scientific Officer	सूचित बिक्री	5,928	$21.77	$129.03K
2026-01-22	Watson David O.	General Counsel	सूचित बिक्री	7,832	$21.77	$170.47K
2026-01-20	Baumal Caroline	Chief Medical Officer	सूचित बिक्री	1,882	$19.79	$37.25K
2026-01-20	Delong Mark Jeffrey	Chief Business & Strat Officer	सूचित बिक्री	1,334	$19.79	$26.4K